RxDoctor Payments Data

Blake Phillips, MD

Neurological Surgery · Little Rock, ARNPI 1730347899

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (36.9%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Medtronic at 45.9% of the total. Reporting peaked in 2024 at $5,828 and has fallen 88.3% since, to $684 in 2025.

$10,152in general payments, 2019–2025

Across 87 payments — averaging $116.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$5K
  • Medical Device Business Services, Inc.$4K
  • Boston Scientific$766
  • Nevro Corp.$331
  • Globus Medical$329
  • Johnson & Johnson$274
  • plus $287 from 5 others

What the payments were for

  • Royalty or licence$3,50034%
  • Travel & lodging$2,90729%
  • Food & beverage$3,74537%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,152 in reported general payments places this provider in the 70th percentile of 64 neurological surgery providers in Arkansas.

See all neurological surgery providers in Arkansas

Medicare billing

Part B allowed, 2024
$380,938
Medicare patients
479
Services billed
1,324

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen124$1,064
Naloxone Hcl12$967
Gabapentin89$962
Celecoxib13$537
Methylprednisolone51$297
Amitriptyline Hcl24$188
Methocarbamol25$183
Diclofenac Sodium14$157
Meloxicam38$95
Diazepam26$51
Tramadol Hcl17$34

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →